Andrea Belluzzi, MD
Belluzzi A. Review: Infliximab increases response and remission rates in fistulizing or treatment-resistant Crohn disease. ACP J Club. 2002;137:91. doi: 10.7326/ACPJC-2002-137-3-091
Download citation file:
Published: ACP J Club 2002;137(3):91.
Learn more about subscription options.
Register Now for a free account.
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only